Showing 7321-7330 of 8692 results for "".
- Pharma Penalties Total $10.2B Over Two Yearshttps://practicaldermatology.com/news/20120928-pharma_penalties_total_102b_over_two_years/2459727/Pharmaceutical manufacturers have reached a total of 74 settlements, totaling $10.2 billion in financial penalties with federal and state governments between November 2, 2010 and July 18, 2012. That's the conclusion of an updated report from P
- Physicians Report Health IT Growing But Systems Laghttps://practicaldermatology.com/news/20120921-physicians_report_health_it_growing_but_systems_lag/2459732/A new Optum Institute/Harris Interactive national survey provides insights into US consumers' willingness to view their medical records and engage with care providers online. The survey was conducted online within the United States among 1,000 US physicians, 2,870 US adults, and 400 US hospital exec
- p53R2 Regulates Proliferation and Chemosensitivity in Melanomahttps://practicaldermatology.com/news/20120918-p53r2_regulates_proliferation_and_chemosensitivity_in_melanoma/2459734/Expression of p53R2 significantly correlates with the depth of invasion and the tumor stage in melanoma, new research shows. (J Dermatol Sci; 68(1):19-24) Furthermore, use of siRNA targeting p53R2 successfully knocked down p53R2 and significantly inhibited the growth of KHm5 and 6 cells. The degree
- CMS Provider Call Today on EHRshttps://practicaldermatology.com/news/20120913-cms_provider_call_today_on_ehrs/2459740/The Centers for Medicare and Medicaid Services will host a 90-minute National Provider Call today, Sept. 13, to discuss the final rule for the Stage 2 electronic health records meaningful use program. The call is free, but prior registration is required.
- Direct-to-Consumer Pharmaceutical Advertising: Minimizing Risks?https://practicaldermatology.com/news/20120912-letter_to_editor_discusses_changes_in_direct-to-consumer_pharmaceutical_advertising/2459741/When prescription drugs switch to over-the-counter status, regulatory oversight of their advertising shifts to the Federal Trade Commission (FTC), potentially leading to reduced focus on warnings about risks and side effects, a new report suggests. While the FDA regulates prescription drug advertisi
- Plastic Surgeons Use ExtendCredit to Provide Financing Services for Patientshttps://practicaldermatology.com/news/20120830-plastic_surgeons_use_extendcredit_to_provide_financing_services_for_patients/2459744/Riverside Plastic Surgery and San Diego-based SpiritLift Plastic Surgery recently started using ExtendCredit.com, an online software platform for creating and managing in-house customer financing plans for small to mid-sized businesses. The two practices now use ExtendCredit's fully automated, onlin
- Christina Cosmeceuticals Launches e-Commerce Websitehttps://practicaldermatology.com/news/20120816-christina_cosmeceuticals_launches_e-commerce_website/2459752/Christina Cosmeceuticals launched their first US e-commerce website for licensed aesthetic professionals. The site allows members to order products and supplies while acting as a resource for spa and aesthetician needs. Content showcases C
- Zein Obagi, MD To Direct 24th Ultimate Skin Health Symposiumhttps://practicaldermatology.com/news/20120807-zein_obagi_md_to_direct_24th_ultimate_skin_health_symposium/2459755/Zein E. Obagi, MD was named director of the 24th Ultimate Skin Health Symposium, a three-day skin rejuvenation program taking place at the Montage Hotel, Beverly Hills, CA, from November 9-11, 2012. Key topics of the symposium will i
- Abbott 2Q Profit Beats Expectations, Humira Sales Growhttps://practicaldermatology.com/news/20120802-abbott_2q_profit_beats_expectations_humira_sales_grow/2459757/Abbott Laboratories announced that second-quarter earnings narrowly beat estimates, fueled by the continued growth of its drug Humira. The company said net income for the quarter declined to $1.75 billion, or $1.08 per share, from $1.94 b
- CryoShape LTD Launches One-time Scar-freezing Treatmenthttps://practicaldermatology.com/news/20120802-cryoshape_ltd_launches_one-time_scar-freezing_treatment/2459758/CryoShape LTD introduced CryoShape, a new technology to reduce or eliminate keloid and hypertrophic scars, at the Aesthetic Plastic Surgery/Anti-Aging Medicine: The Next Generation Symposium in New York City July 20-22, 2012. The product uses a